[go: up one dir, main page]

NO942977D0 - Piperazin og piperidinderivater og anvendelse derav som antipsykotiske midler - Google Patents

Piperazin og piperidinderivater og anvendelse derav som antipsykotiske midler

Info

Publication number
NO942977D0
NO942977D0 NO942977A NO942977A NO942977D0 NO 942977 D0 NO942977 D0 NO 942977D0 NO 942977 A NO942977 A NO 942977A NO 942977 A NO942977 A NO 942977A NO 942977 D0 NO942977 D0 NO 942977D0
Authority
NO
Norway
Prior art keywords
piperazine
piperidine derivatives
antipsychotic agents
antipsychotic
agents
Prior art date
Application number
NO942977A
Other languages
English (en)
Other versions
NO942977L (no
Inventor
Henry Mark Norman
Frank Navas
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO942977D0 publication Critical patent/NO942977D0/no
Publication of NO942977L publication Critical patent/NO942977L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO942977A 1992-02-12 1994-08-11 Piperazin og piperidinderivater og anvendelse derav som antipsykotiske midler NO942977L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds
PCT/GB1993/000285 WO1993016073A1 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics

Publications (2)

Publication Number Publication Date
NO942977D0 true NO942977D0 (no) 1994-08-11
NO942977L NO942977L (no) 1994-10-10

Family

ID=10710223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942977A NO942977L (no) 1992-02-12 1994-08-11 Piperazin og piperidinderivater og anvendelse derav som antipsykotiske midler

Country Status (16)

Country Link
EP (1) EP0625978A1 (no)
JP (1) JPH07503723A (no)
KR (1) KR950700290A (no)
AU (1) AU3460393A (no)
CA (1) CA2117434A1 (no)
CZ (1) CZ194994A3 (no)
FI (1) FI943718A0 (no)
GB (1) GB9202915D0 (no)
HU (1) HUT72309A (no)
IL (1) IL104690A0 (no)
MX (1) MX9300786A (no)
NO (1) NO942977L (no)
RU (1) RU94038064A (no)
SK (1) SK96494A3 (no)
WO (1) WO1993016073A1 (no)
ZA (1) ZA93958B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体
US6001827A (en) * 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
WO1995018117A1 (en) * 1993-12-24 1995-07-06 Suntory Limited Benzothiazine derivative
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
WO1996014297A1 (en) * 1994-11-04 1996-05-17 Sumitomo Pharmaceuticals Company, Limited Novel lactam derivatives
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
US6087364A (en) * 1998-01-29 2000-07-11 Warner-Lambert Company Dopamine D4 receptor antagonists
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
CA2363942A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
AR028685A1 (es) 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
ATE431147T1 (de) 2002-08-22 2009-05-15 Dainippon Sumitomo Pharma Co Mittel zur behandlung des integrationsdysfunktionssyndroms
PT1426049E (pt) 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
KR101113630B1 (ko) 2003-06-23 2012-02-13 다이닛본 스미토모 세이야꾸 가부시끼가이샤 노인성 치매 치료제
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005080976A1 (ja) 2004-02-20 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. 統合失調症の記憶・学習機能障害治療薬のin vivoスクリーニング方法
MX2009007209A (es) * 2007-01-03 2009-10-12 Cortex Pharma Inc Compuestos de [1, 2, 3]-benzotriazinona-sustituidos en la posicion 3 para mejorar las respuestas sinapticas glutamatergicas.
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
WO2013014665A1 (en) * 2011-07-28 2013-01-31 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
JP6423875B2 (ja) * 2013-07-31 2018-11-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung オキソキナゾリニル−ブタンアミド誘導体
CN105669665A (zh) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 哌罗匹隆的制备方法
US11246905B2 (en) 2016-08-15 2022-02-15 President And Fellows Of Harvard College Treating infections using IdsD from Proteus mirabilis
CN115124464B (zh) * 2022-07-04 2023-06-06 新乡学院 一种喹啉二酮磺酰哌嗪杂合体及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (no) * 1974-01-30 1977-09-09 Roussel Uclaf
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体

Also Published As

Publication number Publication date
SK96494A3 (en) 1995-07-11
NO942977L (no) 1994-10-10
RU94038064A (ru) 1997-05-27
GB9202915D0 (en) 1992-03-25
AU3460393A (en) 1993-09-03
FI943718L (fi) 1994-08-11
FI943718A7 (fi) 1994-08-11
IL104690A0 (en) 1993-06-10
HU9402343D0 (en) 1994-10-28
MX9300786A (es) 1994-03-31
WO1993016073A1 (en) 1993-08-19
JPH07503723A (ja) 1995-04-20
KR950700290A (ko) 1995-01-16
CA2117434A1 (en) 1993-08-19
ZA93958B (en) 1994-08-11
HUT72309A (en) 1996-04-29
EP0625978A1 (en) 1994-11-30
FI943718A0 (fi) 1994-08-11
CZ194994A3 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
NO942977D0 (no) Piperazin og piperidinderivater og anvendelse derav som antipsykotiske midler
FI942252A7 (fi) Piperatsiinijohdannaisia
FI964815L (fi) Piperatsiinijohdoksia 5-HT1A antagonisteina
NO990551D0 (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
FI942052L (fi) Heteroaryylipiperidiinejä, -pyrrolidiinejä ja -piperatsiineja ja niiden käyttö antipsykoottisina ja anlgeettisina aineina
NO960371D0 (no) Piperazinderivater som ter
FI942635A7 (fi) Piperatsiinijohdannaiset 5HT1A-antagonisteina
DK1131308T3 (da) Piperazin- og piperidinderivater
FI930799L (fi) Piperazinylderivat
FI921345L (fi) Piperidinderivat
NO180445C (no) 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler
NO984380L (no) Nye piperazin og piperidinforbindelser
DK0839146T3 (da) Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
FI922341A7 (fi) Piperidiini- ja pyrrolidiinijohdannaisia
FI945086A7 (fi) 1-(2H-1-bentsopyran-2-oni-8-yyli)piperatsiinijohdannaisia
FI923664A7 (fi) Piperidiinijohdannaisia
FI955164A7 (fi) Heterosykliset johdannaiset
FI973164L (fi) Antipsykoottisia 4-(1H-indolyl-1-yyli)-1-substituoituja piperidiinijohdannaisia
DE69216260D1 (de) Piperidinderivate
FI953793A7 (fi) Morfoliinijohdannainen
FI931610A7 (fi) Piperatsiinijohdannaisia
NO950327D0 (no) Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler
DE59205281D1 (de) Chirale Piperazin-Derivative
NO962075D0 (no) Amfifiliske derivater av piperazin
MX24301A (es) Agentes antipsicoticos espirociclicos